SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Juli Alonso, Juan Córdoba, Alex Rovira, Brain Magnetic Resonance in Hepatic Encephalopathy, Seminars in Ultrasound, CT and MRI, 2014, 35, 2, 136

    CrossRef

  2. 2
    Chun Yao, Guochu Huang, Meng Wang, Meng Xia, Fan Yao, Dengfeng Niu, Yuer Zhang, Shan Li, Yu Zhong, Chinese herbal medicine formula Jieduhuayu granules improves cognitive and neurophysiological functions in patients with cirrhosis who have minimal hepatic encephalopathy: A randomized controlled trial, Complementary Therapies in Medicine, 2014, 22, 6, 977

    CrossRef

  3. 3
    Jonathan P Sturgeon, Debbie L Shawcross, Recent insights into the pathogenesis of hepatic encephalopathy and treatments, Expert Review of Gastroenterology & Hepatology, 2014, 8, 1, 83

    CrossRef

  4. 4
    Karin Weissenborn, Neurologic Aspects of Systemic Disease Part II, 2014,

    CrossRef

  5. 5
    Valerie Walker, 2014,

    CrossRef

  6. 6
    Iona Coltart, Thomas H. Tranah, Debbie L. Shawcross, Inflammation and hepatic encephalopathy, Archives of Biochemistry and Biophysics, 2013, 536, 2, 189

    CrossRef

  7. 7
    Hanan Mardini, Christopher Record, Pathogenesis of hepatic encephalopathy: lessons from nitrogen challenges in man, Metabolic Brain Disease, 2013, 28, 2, 201

    CrossRef

  8. 8
    Lokesh Jain, Barjesh Chander Sharma, Siddharth Srivastava, Sunil Kumar Puri, Praveen Sharma, Shiv Sarin, Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy, Journal of Gastroenterology and Hepatology, 2013, 28, 7
  9. 9
    Oliviero Riggio, Silvia Nardelli, Federica Moscucci, Chiara Pasquale, Lorenzo Ridola, Manuela Merli, Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt, Clinics in Liver Disease, 2012, 16, 1, 133

    CrossRef

  10. 10
    L. Mpabanzi, N. Deutz, P. C Hayes, C. H. C. Dejong, S. W. M. Olde Damink, R. Jalan, Overnight glucose infusion suppresses renal ammoniagenesis and reduces hyperammonaemia induced by a simulated bleed in cirrhotic patients, Alimentary Pharmacology & Therapeutics, 2012, 35, 8
  11. 11
    Gavin Wright, Balasubramaniyan Vairappan, Vanessa Stadlbauer, Rajeshwar P. Mookerjee, Nathan A. Davies, Rajiv Jalan, Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats, Liver International, 2012, 32, 3
  12. 12
    Lokesh Jain, Barjesh Chander Sharma, Praveen Sharma, Siddharth Srivastava, Amit Agrawal, Shiv Kumar Sarin, Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy, Digestive and Liver Disease, 2012, 44, 12, 1027

    CrossRef

  13. 13
    Saskia Ditisheim, Emiliano Giostra, Pierre R Burkhard, Nicolas Goossens, Gilles Mentha, Antoine Hadengue, Laurent Spahr, A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis, BMC Gastroenterology, 2011, 11, 1, 134

    CrossRef

  14. 14
    Vibhu Vibhas Mittal, Barjesh Chander Sharma, Praveen Sharma, Shiv Kumar Sarin, A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy, European Journal of Gastroenterology & Hepatology, 2011, 23, 8, 725

    CrossRef

  15. 15
    Daniel J. Wilkinson, Nicholas J. Smeeton, Paul C. Castle, Peter W. Watt, Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms?, Metabolic Brain Disease, 2011, 26, 3, 203

    CrossRef

  16. 16
    D.L. Shawcross, Y. Sharifi, J.B. Canavan, A.D. Yeoman, R.D. Abeles, N.J. Taylor, G. Auzinger, W. Bernal, J.A. Wendon, Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis, Journal of Hepatology, 2011, 54, 4, 640

    CrossRef

  17. 17
    Hanan Mardini, Fiona E. Smith, Christopher O. Record, Andrew M. Blamire, Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia, Journal of Hepatology, 2011, 54, 6, 1154

    CrossRef

  18. 18
    Debbie L. Shawcross, Shabnam S. Shabbir, Nicholas J. Taylor, Robin D. Hughes, Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis, Hepatology, 2010, 51, 3
  19. 19
    Daniel J. Wilkinson, Nicholas J. Smeeton, Peter W. Watt, Ammonia metabolism, the brain and fatigue; revisiting the link, Progress in Neurobiology, 2010, 91, 3, 200

    CrossRef

  20. 20
    S. K. Yadav, S. Saksena, A. Srivastava, A. Srivastava, V. A. Saraswat, M. A. Thomas, R. K. S. Rathore, R. K. Gupta, Brain MR Imaging and 1H-MR Spectroscopy Changes in Patients with Extrahepatic Portal Vein Obstruction from Early Childhood to Adulthood, American Journal of Neuroradiology, 2010, 31, 7, 1337

    CrossRef

  21. 21
    Santosh K. Yadav, Anshu Srivastava, Arti Srivastava, Michael A. Thomas, Jaya Agarwal, Chandra M. Pandey, Richa Lal, Surender K. Yachha, Vivek A. Saraswat, Rakesh K. Gupta, Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency, Journal of Hepatology, 2010, 52, 3, 348

    CrossRef

  22. You have free access to this content22
    Radha K Dhiman, Vivek A Saraswat, Barjesh K Sharma, Shiv K Sarin, Yogesh K Chawla, Roger Butterworth, Ajay Duseja, Rakesh Aggarwal, Deepak Amarapurkar, Praveen Sharma, Kaushal Madan, Samir Shah, Avnish K Seth, Rakesh K Gupta, Abraham Koshy, Ramesh R Rai, Jang B. Dilawari, Sri Prakash Mishra, Subrat K Acharya, Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver, Journal of Gastroenterology and Hepatology, 2010, 25, 6
  23. 23
    Gavin Wright, Robin Soper, Heather F. Brooks, Vanessa Stadlbauer, Balasubramaniyan Vairappan, Nathan A. Davies, Fausto Andreola, Stephen Hodges, Raymond F. Moss, D. Ceri Davies, Rajiv Jalan, Role of aquaporin-4 in the development of brain oedema in liver failure, Journal of Hepatology, 2010, 53, 1, 91

    CrossRef

  24. 24
    Nathan A. Davies, Gavin Wright, Lars M. Ytrebø, Vanessa Stadlbauer, Ole-Martin Fuskevåg, Claudia Zwingmann, D. Ceri Davies, Abeba Habtesion, Stephen J. Hodges, Rajiv Jalan, L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats, Hepatology, 2009, 50, 1
  25. 25
    Radha K. Dhiman, Yogesh K. Chawla, Minimal hepatic encephalopathy, Indian Journal of Gastroenterology, 2009, 28, 1, 5

    CrossRef

  26. 26
    Debbie L. Shawcross, Gavin A. K. Wright, Vanessa Stadlbauer, Stephen J. Hodges, Nathan A. Davies, Caroline Wheeler-Jones, Andrew A. Pitsillides, Rajiv Jalan, Ammonia impairs neutrophil phagocytic function in liver disease, Hepatology, 2008, 48, 4
  27. 27
    Gavin Wright, Nathan A. Davies, Debbie L. Shawcross, Stephen J. Hodges, Claudia Zwingmann, Heather F. Brooks, Ali R. Mani, David Harry, Vanessa Stadlbauer, Zheng Zou, Roger Williams, Ceri Davies, Kevin P. Moore, Rajiv Jalan, Endotoxemia produces coma and brain swelling in bile duct ligated rats, Hepatology, 2007, 45, 6
  28. 28
    Srinivasa Prasad, Radha K. Dhiman, Ajay Duseja, Yogesh K. Chawla, Arpita Sharma, Ritesh Agarwal, Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy, Hepatology, 2007, 45, 3
  29. 29
    Radha K. Dhiman, Ajay Duseja, Yogesh K. Chawla, Reply:, Hepatology, 2007, 46, 3
  30. 30
    D. L. Shawcross, G. Wright, S. W. M. Olde Damink, R. Jalan, Role of ammonia and inflammation in minimal hepatic encephalopathy, Metabolic Brain Disease, 2007, 22, 1, 125

    CrossRef

  31. 31
    Hanan Al Mardini, Andrew Douglass, Christopher Record, Amino Acid Challenge in Patients with Cirrhosis and Control Subjects: Ammonia, Plasma Amino Acid and EEG Changes, Metabolic Brain Disease, 2006, 21, 1, 1

    CrossRef

  32. 32
    Rodrigo Jover, Regina Rodrigo, Vicente Felipo, Ricardo Insausti, Javier Sáez-Valero, M. Salud García-Ayllón, Isabel Suárez, Asunción Candela, Antonio Compañ, Angel Esteban, Omar Cauli, Eva Ausó, Erika Rodríguez, Ana Gutiérrez, Eva Girona, Slaven Erceg, Pere Berbel, Miguel Pérez-Mateo, Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis, Hepatology, 2006, 43, 6
  33. 33
    Juan C. Quero Guillén, Juan M. Herrerías Gutiérrez, Diagnostic methods in hepatic encephalopathy, Clinica Chimica Acta, 2006, 365, 1-2, 1

    CrossRef

  34. 34
    Elwyn Elias, Liver failure and liver disease, Hepatology, 2006, 43, S1
  35. 35
    Dieter Häussinger, Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis, Hepatology, 2006, 43, 6
  36. 36
    Beatriz Mínguez, Juan Carlos García-Pagán, Jaume Bosch, Juan Turnes, Juli Alonso, Alex Rovira, Juan Córdoba, Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy, Hepatology, 2006, 43, 4
  37. 37
    Omar Cauli, Marta Llansola, Regina Rodrigo, Nisrin El Mlili, Mohammed Errami, Vicente Felipo, Altered Modulation of Motor Activity by Group I Metabotropic Glutamate Receptors in the Nucleus Accumbens in Hyperammonemic Rats, Metabolic Brain Disease, 2005, 20, 4, 347

    CrossRef

  38. 38
    D. L. Shawcross, S. W. M. Olde Damink, R. F. Butterworth, R. Jalan, Ammonia and Hepatic Encephalopathy: The More Things Change, the More They Remain the Same, Metabolic Brain Disease, 2005, 20, 3, 169

    CrossRef

  39. 39
    Rodrigo Jover, Enriquede Madaria, Vicente Felipo, Regina Rodrigo, Asunción Candela, Antonio Compañ, Animal Models in the Study of Episodic Hepatic Encephalopathy in Cirrhosis, Metabolic Brain Disease, 2005, 20, 4, 399

    CrossRef

  40. 40
    Debbie Shawcross, Rajiv Jalan, Dispelling myths in the treatment of hepatic encephalopathy, The Lancet, 2005, 365, 9457, 431

    CrossRef

  41. 41
    Ronald F. Pfeiffer, NEUROLOGICAL DYSFUNCTION IN GASTROINTESTINAL DISEASES, CONTINUUM: Lifelong Learning in Neurology, 2005, 11, 59

    CrossRef

  42. 42
    Andre M De Wolf, Preoperative optimization of patients with liver disease, Current Opinion in Anaesthesiology, 2005, 18, 3, 325

    CrossRef

  43. 43
    Manuel Romero-Gómez, Role of Phosphate-Activated Glutaminase in the Pathogenesis of Hepatic Encephalopathy, Metabolic Brain Disease, 2005, 20, 4, 319

    CrossRef

  44. 44
    Susan J. Hemmings, Xiuyuan Song, The effects of dietary flaxseed on the Fischer 344 rat. III. Protection against CCl4-induced liver injury, Cell Biochemistry and Function, 2005, 23, 6
  45. 45
    Manuel Romero-Gómez, Rosa Ramos-Guerrero, Lourdes Grande, Laura Collantes de Terán, Raquel Corpas, Inés Camacho, Juan D. Bautista, Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy, Journal of Hepatology, 2004, 41, 1, 49

    CrossRef

  46. 46
    Christopher Rose, Rajiv Jalan, Is minimal hepatic encephalopathy completely reversible following liver transplantation?, Liver Transplantation, 2004, 10, 1
  47. 47
    Guadalupe Garcia-Tsao, Portal hypertension, Current Opinion in Gastroenterology, 2004, 20, 3, 254

    CrossRef

  48. 48
    Debbie L Shawcross, Nathan A Davies, Roger Williams, Rajiv Jalan, Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis, Journal of Hepatology, 2004, 40, 2, 247

    CrossRef

  49. 49
    Queralt Jordano, Juan Córdoba, Manuel Pena, Valor de la determinación sérica de S-100β en la encefalopatía hepática, Medicina Clínica, 2003, 121, 18, 718

    CrossRef